Business Description
OptiBiotix Health PLC
ISIN : GB00BP0RTP38
Total Employee Number:
9Description
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.38 | |||||
Beneish M-Score | -4.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.9 | |||||
3-Year EPS without NRI Growth Rate | 25.9 | |||||
3-Year FCF Growth Rate | -6.7 | |||||
3-Year Book Growth Rate | -20.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.35 | |||||
9-Day RSI | 73.75 | |||||
14-Day RSI | 71.28 | |||||
3-1 Month Momentum % | 21.05 | |||||
6-1 Month Momentum % | 45.26 | |||||
12-1 Month Momentum % | -43.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.27 | |||||
Quick Ratio | 3.49 | |||||
Cash Ratio | 2.7 | |||||
Days Inventory | 203.44 | |||||
Days Sales Outstanding | 86.4 | |||||
Days Payable | 198.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.2 | |||||
Shareholder Yield % | -11.26 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.66 | |||||
Operating Margin % | -268.61 | |||||
Net Margin % | -333.62 | |||||
EBITDA Margin % | -251.03 | |||||
FCF Margin % | -151.96 | |||||
OCF Margin % | -151.96 | |||||
ROE % | -50.52 | |||||
ROA % | -46.51 | |||||
ROIC % | -44.21 | |||||
3-Year ROIIC % | -157.53 | |||||
ROC (Joel Greenblatt) % | -1560.8 | |||||
ROCE % | -39.35 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 10.68 | |||||
PS Ratio | 5.86 | |||||
PB Ratio | 1.06 | |||||
Price-to-Tangible-Book | 1.22 | |||||
EV-to-EBIT | -1.8 | |||||
EV-to-EBITDA | -1.92 | |||||
EV-to-Forward-EBITDA | 186.34 | |||||
EV-to-Revenue | 4.83 | |||||
EV-to-Forward-Revenue | 4.94 | |||||
EV-to-FCF | -3.18 | |||||
Price-to-GF-Value | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 7.3 | |||||
Earnings Yield (Greenblatt) % | -55.56 | |||||
FCF Yield % | -26.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OptiBiotix Health PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.351 | ||
| EPS (TTM) (€) | -0.045 | ||
| Beta | 4.9477 | ||
| 3-Year Sharpe Ratio | 0.35 | ||
| 3-Year Sortino Ratio | 1.26 | ||
| Volatility % | 51.9 | ||
| 14-Day RSI | 71.28 | ||
| 14-Day ATR (€) | 0.00262 | ||
| 20-Day SMA (€) | 0.069325 | ||
| 12-1 Month Momentum % | -43.44 | ||
| 52-Week Range (€) | 0.038 - 0.144 | ||
| Shares Outstanding (Mil) | 103.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OptiBiotix Health PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OptiBiotix Health PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-09-16 | In 72 days | ||
| Fourth quarter earnings conference call for 2025 | 2026-07-03 13:00 | 0.07 (-1.37%) | ||
| Fourth quarter earnings results for 2025 | 2026-07-03 | 0.07 (-1.37%) | ||
| General meeting for 2025 | 2026-06-23 13:00 | 0.07 (+1.54%) | ||
| Annual report for 2025 | 2026-05-28 | 0.06 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-09-16 | 0.11 (+2.73%) | ||
| General meeting for 2024 | 2025-08-06 11:00 | 0.12 (+2.48%) | ||
| Fourth quarter earnings conference call for 2024 | 2025-07-03 13:00 | 0.12 (-0.82%) | ||
| Annual report for 2024 | 2025-06-30 | 0.13 (+2.44%) | ||
| Fourth quarter earnings results for 2024 | 2025-06-30 | 0.13 (+2.44%) |
Show
Entries
OptiBiotix Health PLC Frequently Asked Questions
What is OptiBiotix Health PLC(STU:OB3)'s stock price today?
The current price of STU:OB3 is €0.07. The 52 week high of STU:OB3 is €0.14 and 52 week low is €0.04.
When is next earnings date of OptiBiotix Health PLC(STU:OB3)?
The next earnings date of OptiBiotix Health PLC(STU:OB3) is 2026-09-16 Est..
Does OptiBiotix Health PLC(STU:OB3) pay dividends? If so, how much?
OptiBiotix Health PLC(STU:OB3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on OptiBiotix Health PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers